CJC-1295 + GHRP-2 Blend
Peptide Blend
A compounded blend of CJC-1295 (GHRH analogue) and GHRP-2 (ghrelin receptor agonist) for synergistic growth hormone stimulation through complementary receptor pathways.
Find Clinics Offering CJC-1295 + GHRP-2 Blend
No clinics in our directory yet. Browse all clinics.
Related Peptides
Adamax is a branded compounded peptide blend typically combining CJC-1295 DAC, Ipamorelin, and BPC-157, formulated to simultaneously stimulate growth hormone secretion, promote tissue repair, and support recovery — often available as a single reconstitution vial.
CagriSema, a compounded combination of the amylin analogue cagrilintide and the GLP-1 agonist semaglutide, studied in Phase 3 REDEFINE trials with approximately 22.7% body weight reduction at 68 weeks.
A triple-peptide compounded blend combining AOD-9604 (fat-mobilizing GH fragment) with CJC-1295 and ipamorelin for comprehensive GH-axis optimization with targeted lipolysis.
A compounded blend combining ipamorelin (ghrelin receptor agonist) with tesamorelin (GHRH analogue) for synergistic GH secretion with tesamorelin's additional visceral fat-reducing properties.
Continue Reading
Articles about CJC-1295 + GHRP-2 Blend and related topics
How to Reconstitute BPC-157: Step-by-Step Mixing Guide (2026)
A detailed, clinician-informed guide to BPC-157 reconstitution — covering diluent selection, step-by-step mixing instructions, concentration math with worked examples, storage requirements, and common mistakes that destroy peptide potency.
Peptide Sciences Shuts Down: What Happened and What It Means
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
How to Get Retatrutide in 2026 (Legit Options & Safety Checklist)
Looking for where to buy retatrutide for research use? Here’s a supplier checklist (COAs, testing, reviews, red flags) plus the clinical-trial pathway for legitimate access.
MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.